SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-093531
Filing Date
2016-04-08
Accepted
2016-04-08 17:15:28
Documents
3
Period of Report
2016-04-05
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v436584_8k.htm 8-K 21239
2 EXHIBIT 16.1 v436584_ex16-1.htm EX-16.1 6271
3 GRAPHIC image_001.jpg GRAPHIC 2159
  Complete submission text file 0001144204-16-093531.txt   31940
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 161563418
SIC: 2834 Pharmaceutical Preparations